Indiana Speech Language Pathologists Continuing Education and License Renewals

English: Speech-Language Pathology

English: Speech-Language Pathology (Photo credit: Wikipedia)

Indiana-licensed speech language pathologists have a biennial license renewal with a December 31st deadline, odd years. Thirty-six hours (36) of continuing education are required in order to renew a license. Of the 36 hours, six (6) hours from home study (self study) are allowed if ASHA approved. Courses must pertain to the speech language pathology or audiology professions.

Continuing education ensures the best possible standards for the speech language pathology profession. All licensed speech language pathologists are required to participate in continuing education as a condition of licensing.

Professional Development Resources is approved by the Continuing Education Board of the American Speech-Language-Hearing Association (ASHA) to provide continuing education activities in speech-language pathology and audiology. See course website for number of ASHA CEUs, instructional level and content area. ASHA CE Provider approval does not imply endorsement of course content, specific products or clincial procedures. CEUs are awarded by the ASHA CE Registry upon receipt of the CEU Participant Form from the ASHA Approved CE Provider. Please note that the completion date that appears on ASHA transcripts is the last day of the quarter, regardless of when the course was completed. Provider #AAUM

Requirements for Continuing Education

Speech language pathologists licensed in the state of Indiana have a license renewal every two years with a December 31st deadline, odd years. Thirty-six (36) continuing education hours are required in order to renew a license. Out of the 36 hours, six (6) hours are allowed from home study (self study) if ASHA approved. Courses must pertain to the speech language pathology or audiology professions.

Information obtained from the Indiana Speech Language Pathology & Audiology Board on November 25, 2013.

 

Enhanced by Zemanta

Comments are closed.